Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

ClinicalTrials.gov ID: NCT03689244

Public ClinicalTrials.gov record NCT03689244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Group-sequential, Adaptive, Phase 3 Study With Open-label Extension Period to Assess the Efficacy and Safety of Selexipag as an add-on to Standard of Care Therapy in Subjects With Inoperable or Persistent/Recurrent After Surgical and/or Interventional Treatment Chronic Thromboembolic Pulmonary Hypertension

Study identification

NCT ID
NCT03689244
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Actelion
Industry
Enrollment
128 participants

Conditions and interventions

Interventions

  • Selexipag Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2019
Primary completion
Jun 6, 2022
Completion
Jun 6, 2022
Last update posted
Jun 20, 2024

2019 – 2022

United States locations

U.S. sites
32
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
University of California San Diego Medical Center La Jolla California 92037
University of Southern California, Keck School of Medicine Los Angeles California 90033
University of Colorado Anschutz Medical Campus Aurora Colorado 80045
Colorado Springs Pulmonary Consultants Colorado Springs Colorado 80907
South Denver Cardiology Associates PC Littleton Colorado 80120
Mayo Clinic in Florida Jacksonville Florida 32259
Piedmont Healthcare Atlanta Georgia 30309
Emory University Atlanta Georgia 30322
Northwestern University Feinberg School of Medicine Chicago Illinois 60611
University of Chicago Hospitals - Chicago Chicago Illinois 60637
Advocate Christ Medical Center Oak Lawn Illinois 60453
University of Maryland Baltimore Maryland 21201
University of Michigan Ann Arbor Michigan 48109
Sparrow Clinical Research Institute Lansing Michigan 48912
Mayo Clinic Rochester Minnesota 55905
Washington University in St. Louis St Louis Missouri 63110
University of Nebraska Medical Center Omaha Nebraska 68198
St. Mary's Cardiology Reno Nevada 89503
University of New Mexico Clinical & Translational Science Center Albuquerque New Mexico 87131
Duke University Medical Center Durham North Carolina 27710
University of Cincinnati Medical Center Cincinnati Ohio 45267
Cleveland Clinic Cleveland Ohio 44195
Temple University Hospital Philadelphia Pennsylvania 19140-5103
Allegheny Pittsburgh Pennsylvania 15212
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
University of Texas Southwestern Medical Center Dallas Texas 75390
Houston Methodist Hospital Houston Texas 77030
Baylor Scott & White Research Institute at The Heart Hospital Baylor Plano Plano Texas 75093
Intermountain Medical Center Murray Utah 84175
University of Utah Cardiovascular Center Salt Lake City Utah 84132
Medical College of Wisconsin Froedtert Hospital Milwaukee Wisconsin 53211
Aurora Saint Lukes Medical Center Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 130 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03689244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 20, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03689244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →